Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
16.460
+0.820
+(5.24%)
At close: 4:08:04 PM GMT+8
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Fang (Jianmin) Chief Executive Officer | Sale | Jan 16, 2023 | 21,745,000 |
| He (Ruyi) Director (Executive) | Sale | May 2, 2024 | 0 |
| Wang (Weidong) Chairman of the Board | Other | Sep 30, 2024 | 3,284,041 |
Related Tickers
2315.HK Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
8.000
-2.44%
1952.HK Everest Medicines Limited
46.450
+3.68%
688578.SS Shanghai Allist Pharmaceuticals Co., Ltd.
76.30
-2.03%
1530.HK 3SBIO
6.800
-1.31%
2162.HK Keymed Biosciences Inc.
35.350
-4.07%
9969.HK InnoCare Pharma Limited
7.890
+1.68%
2616.HK CStone Pharmaceuticals
3.360
+8.39%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
213.200
+3.60%
0690.HK UNI-BIO GROUP
0.069
+6.15%
6996.HK Antengene Corporation Limited
2.220
+4.23%